ALATHARI, ZAYD   VENABLE LLP
21
Betreute Anmeldungen
Technische BereichePatente
Biotechnologie6
Andere Spezialmaschinen3
Grundsätzliche Werkstoffchemie3
Fördertechnik2
Pharmazeutika2

Heimatländer der Klienten

Zusammenfassung

ALATHARI, Zayd ist besonders erfahren in den Technologien „Biotechnologie“ und „Grundsätzliche Werkstoffchemie“. 48% aller Patente wurden im Bereich „(Bio-)Chemie“ betreut. Die wichtigsten Klienten sind „THE JOHNS HOPKINS UNIVERSITY“ und „TARO PHARMACEUTICALS NORTH AMERICA, INC.“. Besonders viele Patentanmeldungen wurden in den Jahren 2007 und 2006 betreut. Die Klienten stammen oftmals aus USA.

Patente nach Jahren

Patente nach Bereichen

10
Patentanmeldungen
4
Patentanmeldungen

Patente nach Anmeldern

RangNameLandPatente
1THE JOHNS HOPKINS UNIVERSITYUSA6
2TARO PHARMACEUTICALS NORTH AMERICA, INC.Israel4
3TEVA PHARMACEUTICALS USA, INC.USA4
4GRAHAM PACKAGING COMPANY, L.P.USA2
5VIRAL GENETICS, INC.Bulgarien2
6EX-TEK, LLCUSA1
7PONDICHERRY BIOTECH PRIVATE LIMITEDIndien1
8UNITED STATES SOYBEAN EXPORT COUNCILUSA1
9UNIVERSITY OF TENNESSEE RESEARCH FOUNDATIONUSA1

Letzte Anmeldungen

PublikationsnummerTitelPatentanmelderJahr
WO2012021632GENERATION AND USE OF PLURIPOTENT STEM CELLSTHE JOHNS HOPKINS UNIVERSITY
2012
WO2012015938OBLIGATE HETERODIMER VARIANTS OF FOKI CLEAVAGE DOMAINPONDICHERRY BIOTECH PRIVATE LIMITED
THE JOHNS HOPKINS UNIVERSITY
2012
WO2011160048METHODS OF IDENTIFYING THERAPEUTIC AGENTS FOR TREATING PERSISTER AND BACTERIAL INFECTIONTHE JOHNS HOPKINS UNIVERSITY
2011
WO2010141711SKIN TREATMENT COMPOSITIONSEX-TEK, LLC
2010
WO2010039988THROMBOXANE GENERATION ANALYSIS FOR CARDIOVASCULAR EVENTSTHE JOHNS HOPKINS UNIVERSITY
2010
WO2010039992PLATELET FUNCTION ANALYSIS FOR ADVERSE CARDIOVASCULAR EVENTSTHE JOHNS HOPKINS UNIVERSITY
2010
WO2009111088ANTITUMOR IMMUNIZATION BY LIPOSOMAL DELIVERY OF VACCINE TO THE SPLEENTHE JOHNS HOPKINS UNIVERSITY
2009
WO2009085987APPARATUS AND METHOD FOR OFFSHORE OCEAN CAGE AQUACULTUREUNITED STATES SOYBEAN EXPORT COUNCIL
2009
WO2007136824HIGH-YIELD BACITRACIN-PRODUCING MICROORGANISMTEVA PHARMACEUTICALS USA, INC.
2007
WO2007127218STREPTOMYCES-DERIVED ANTIMICROBIAL COMPOUND AND METHOD OF USING SAME AGAINST ANTIBIOTIC-RESISTANT BACTERIATEVA PHARMACEUTICALS USA, INC.
2007
WO2007127293NOVEL STREPTOMYCES-DERIVED ANTIMICROBIAL COMPOUND AND METHOD OF USING SAME AGAINST ANTIBIOTIC-RESISTANT BACTERIATEVA PHARMACEUTICALS USA, INC.
2007
WO2007117605NOVEL SPILL-RESISTANT FORMULATIONS COMPRISING HYDROCOLLOIDAL POLYMERSTARO PHARMACEUTICALS NORTH AMERICA, INC.
2007
WO2007092318SPILL RESISTANT ANTIBIOTIC FORMULATIONSTARO PHARMACEUTICALS NORTH AMERICA, INC.
2007
WO2007067508PHARMACEUTICAL FORMULATION CONTAINING PHENYTOIN SODIUM AND MAGNESIUM STEARATETARO PHARMACEUTICALS NORTH AMERICA, INC.
2007
WO2007041285COMPLEXES OF INACTIVATED PEPSIN FRACTION AND HEAT SHOCK PROTEINVIRAL GENETICS, INC.
2007
WO2007041422MULTI-PANEL PLASTIC CONTAINERGRAHAM PACKAGING COMPANY, L.P.
2007
WO2007019184ORAL SUSPENSION OF PREDNISOLONE ACETATETARO PHARMACEUTICALS NORTH AMERICA, INC.
2007
WO2007008576OXCARBAZEPINE FORMULATIONTEVA PHARMACEUTICALS USA, INC.
2007
WO2006110731STABLE DAIRY COMPONENTS EFFECTIVE FOR FAT LOSSUNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
2006
WO2006078581INACTIVATED PEPSIN FRACTION, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR DETECTING AND TREATING DISEASESVIRAL GENETICS, INC.
2006
WO2006060351BLOW MOULDED CONTAINER, METHOD AND MOULDGRAHAM PACKAGING COMPANY, L.P.
2006